---
name: Phosphorex
slug: phosphorex
site: cdmo
website_domain: phosphorex.com
summary: Phosphorex specializes in advanced drug delivery system design and optimization, offering formulation development, process design, analytical expertise, and tech transfer services for gene therapies, mRNA, and other complex therapeutics.
tagline: Advanced drug delivery system design and formulation optimization for complex therapeutics.
founded_year: 
employee_count_band: 
employee_count_label: 
parent_name: 
parent_slug: 
hq_country: 
tier2_domain_verified: false
updated_at: 2026-10-12T07:01:40.248Z
services_count: 2
modalities_count: 3
indications_count: 0
locations_count: 1
review_signal_gate: closed
generated_by: BioBM Editorial AI
---

# Phosphorex

Advanced drug delivery system design and formulation optimization for complex therapeutics.

Listed on cdmo.directory.

## Summary

Phosphorex specializes in advanced drug delivery system design and optimization, offering formulation development, process design, analytical expertise, and tech transfer services for gene therapies, mRNA, and other complex therapeutics.

## Services

- Analytical Method Development & Validation
- Translational Research

## Modalities

- Gene Therapy
- mRNA
- Oligonucleotide

## Locations

- Headquarters

## Long description

## Drug Delivery Expertise

Phosphorex operates the Phosphorex Drug Delivery Engine, a specialized platform focused on bridging the gap between promising preclinical biology and clinical reality through advanced drug delivery system design. The company addresses critical challenges in potency, immunogenicity, biodistribution, and patient safety.

## Core Capabilities

- **Formulation Optimization:** Tailored formulation design across non-viral drug delivery platforms
- **Process Design & CMC:** Scalable, commercializable process development with critical quality attribute control
- **Analytical Expertise:** Comprehensive analytical support for drug delivery systems
- **Tech Transfer & Troubleshooting:** Process optimization, scale-up support, and technical problem-solving
- **Benchmarking & Screening:** Rapid evaluation of multiple formulation systems to identify optimal candidates

## Modality Focus

The company demonstrates particular expertise in lipid nanoparticle (LNP) formulations for gene-editing therapies and other advanced modalities, with demonstrated capability in small-scale batch production (mg to 85 mg scale) and support for preclinical efficacy studies in rodent models.

## Related companies

- [uBriGene](/companies/ubrigene) (Analytical Method Development & Validation, Translational Research) — [Compare](/compare/phosphorex/ubrigene)
- [AM Chemicals LLC](/companies/amchemicals) (Oligonucleotide) — [Compare](/compare/amchemicals/phosphorex)
- [VVector Bio](/companies/vvectorbio) (Translational Research, Gene Therapy) — [Compare](/compare/phosphorex/vvectorbio)
- [ADViRNA](/companies/advirna) (Translational Research, Oligonucleotide) — [Compare](/compare/advirna/phosphorex)
- [Genevoyager (Wuhan) Co., Ltd.](/companies/genevoyager-2) (Analytical Method Development & Validation, Translational Research) — [Compare](/compare/genevoyager-2/phosphorex)
- [Thermo Fisher Scientific](/companies/thermofisher) (Analytical Method Development & Validation, Gene Therapy) — [Compare](/compare/phosphorex/thermofisher)
- [Viralgen](/companies/viralgen) (Analytical Method Development & Validation, Gene Therapy) — [Compare](/compare/phosphorex/viralgen)
- [ProBio](/companies/probio) (Analytical Method Development & Validation, Gene Therapy) — [Compare](/compare/phosphorex/probio)

_Profile last updated: 2026-10-12T07:01:40.248Z. Profile facts may include AI-assisted enrichment._

Auto-generated by BioBM Editorial AI for machine-readable profile access.